NxStage Medical Inc
Why Abiomed’s Product Pipeline Looks Promising
Abiomed (ABMD) is strategically focused on the market penetration of the company’s family of Impella heart pumps.
A Look at NxStage Medical’s Financial Performance
NxStage Medical (NXTM) generated revenue of $393.9 million in 2017 compared to $366.3 million in 2016.